1. Zeiler, H. J., Grohe, K.: Antibacterial activity of the metabolites of ciprofloxacin identified in human urine. 24th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington 1984, Abstract No. 983.
2. Felmingham, D., O'Hare, M. D., Robbins, M. J., Wall, R. A., Williams, A. H., Cremer, A. W., Ridgeway, G. L., Grüneberg, R. N. Comparativein vitro studies with 4-quinolone antimicrobials. Drug Exptl. Clin. Res. 6 (1985) 317–329.
3. Inoue, M., Mitsuhashi, S.: In vitro andin vivo antibacterial activities of BAY o 9867. 14th International Congress of Chemotherapy, Kyoto 1985, Abstract No. WS 6-3.
4. Höffken, G., Lode, H., Prinzing, C., Borner, K., Koeppe, P. Pharmacokinetics of ciprofloxacin after oral and parenteral administration. Antimicrob. Agents Chemother. 27 (1985) 375–379.
5. Wise, R., Lockley, R. M., Webberly, M., Dent, J. Pharmacokinetics of intravenously administered ciprofloxacin. Antimicrob. Agents Chemother. 26 (1984) 208–210.